期刊文献+

重组人白介素-15理化对照品的分析鉴定 被引量:1

Evaluation of Recombinant Human Interleukin-15 Reference Standard
原文传递
导出
摘要 目的为了对产品质量进行有效的控制,根据《中国药典》要求,对重组人白介素^(-1)5理化对照品进行分析鉴定。方法参照2010年版《中国药典》三部,测定该样品的生物学活性、蛋白含量、纯度、等电点等指标;通过测定N-末端氨基酸序列、质谱相对分子质量与液质肽图,确证其一级结构。结果该样品的比活性为1.03×107IU·mg^(-1);蛋白含量为(0.879±0.065)mg·m L^(-1);非还原SDS-PAGE纯度为100.0%;分子排阻色谱纯度为100.0%;等电点测定结果为5.2;以上结果均符合质量标准要求。实测质谱相对分子质量(12 900.80)与理论值(12 900.71)一致;氨基酸序列与理论一致,氨基酸覆盖率100%;二硫键连接方式为Cys36-Cys86、Cys43-Cys89,与文献报道相符。结论该理化对照品质量合格、氨基酸序列正确,可用于白介素^(-1)5的常规质量控制。 OBJECTIVE To evaluate the reference standard of recombinant human interleukin-15 ( IL-15 ) for the effective quality control of IL-15 products according to the requirements of Chinese Pharmacopeia. METHODS The biological activity, concentration, purity, and isoelectric point of IL-15 were tested according to Chinese Pharmacopeia (volume m, 2010 edition). The primary structure was confirmed by analyzing the N-terminal amino acid sequence and relative molecular mass and peptide mass mapping. RE- SULTS The measured biological activity of IL-15 was 1.03×107IU·mg-1, the content was (0.879±0.065)mg·m L-1 , the pu- rities tested by SDS-PAGE and SEC-HPLC were all 100% , and the isoelectric point was 5.2, which all met the criteria specified in the quality standard. The observed relative molecular mass, 12 900. 80, was consistent with theoretical value ( 12 900. 71 ). Its amino acid sequence was verified with coverage of 100%. The disulfide bonds were identified to to be Cys36-Cys86/CyM3-Cys89, which was in accordance with the published papers. CONCLUSION This reference standard, which is qualified and has correct amino acid sequence, can be used for the routine quality control of IL-15.
出处 《中国药学杂志》 CAS CSCD 北大核心 2016年第13期1076-1079,共4页 Chinese Pharmaceutical Journal
基金 十三五科技重大专项课题资助项目(2015ZX09501008)
关键词 白介素-15 理化对照品 氨基酸序列 二硫键 interleukin 15 reference standard amino acid sequence disulfide bond
  • 相关文献

参考文献15

  • 1GRABSTEIN K H, EISENMAN J, SHANEBECK K, et al. Clo- ning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor[J]. Science, 1994, 264(5161 ) :965- 968.
  • 2GIRl J G, ANDERSON D M, KUMAKI S, et al. IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2[J]. J Leukoc Biol, 1995, 57(5) :763-766.
  • 3WILKINSON P C, LIEW F Y. Chemoattraction of human blood T lymphocytes by interleukin-15 [ J]. J Exp Med, 1995, 181 (3) :1255-1259.
  • 4ARMITAGE R J, MACDUFF B M, EISENMAN J, et al. IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation[J]. J Immunol, 1995, 154(2) :483-490.
  • 5YEGHIAZARIANS Y, HONBO N, IMHOF I, et al. IL-15: a novel prosurvival signaling pathway in cardiomyocytes [ J ]. J Car- diovasc Pharmacol, 2014, 63 (5) :406-411.
  • 6SHENOY A R, KIRSCHNEK S, HJCKER G. IL-15 regulates Bcl-2 family members Bim and Mcl-1 through JAK/STAT and H3K/AKT pathways in T cells[J]. Eur J Immunol, 2014, 44 ( 8 ) :2500-2507.
  • 7TAMZALIT F, BARBIEUX I, PLET A, et al. IL-15, IL-15Ret complex shedding following trans-presentation is essential for the survival of IL-15 responding NK and T cells[J]. Proc Natl Acad Sci USA, 2014, 111 (23) :8565-8570.
  • 8YU P, BAMFORD R N, WALDMANN T A. IL-15-de- pendent CD8 + CD122 + T cells ameliorate experimental autoim- mune encephalomyelitis by modulating IL-17 production by CI)4 + T cells[ J ]. Eur J Immunol, 2014, 44 ( 11 ) :3330-3341.
  • 9ABADIE V, JABRI B. IL-15: a central regulator of celiac dis- ease immunopathology[ J]. Immunol Rev, 2014, 260 ( 1 ) : 221- 234.
  • 10JABRI B, ABADIE V. IL-15 functions as a danger signal to reg- ulate tissue-resident T cells and tissue destruction [ J ]. Nat Rev Irnmunol, 2015, 15(12) :771-783.

同被引文献8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部